CAR19BCMA CAR-T Cells for the Treatment of R/R Plasma Cell Neoplasms

Clinical trial NCT07077330 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07077330
Sponsor: Chinese PLA General Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Plasma Cell Neoplasms

Start date: 2025-08-01
Primary completion: 2026-08-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.